Published by Benjamin Chiou on 23rd May 2025
(Sharecast News) - Pharma group GSK has announced that US regulators have approved for use its Nucala treatment for adults with chronic obstructive pulmonary disease (COPD) following positive results from phase III trials.
URL: http://www.digitallook.com/dl/news/story/35102445/...